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PreviewsGetting fat: Two new players
in molecular adipogenesis
A transcription factor cascade drives adipogenesis. Two new members of this cascade have been uncovered—Kruppel-
like factor 5 (KLF5), which is induced by C/EBPβ and δ and acts in concert with C/EBPα, β, and δ to activate PPARγ2
expression, and Krox20, which is upstream of C/EBPβ expression and one of the earliest factors induced during adipo-
genesis.Mammals have developed a mechanism f
to store energy in the form of fat or tri- a
cacylglycerols for use in time of fasting.
Papers published in this and last 3
cmonth’s issues of Cell Metabolism ad-
dress the molecular mechanism of adi- e
apogenesis, in which undifferentiated
precursor cells are stimulated to be- e
Pcome fat storage cells (Chen et al., 2005
[this issue]; Oishi et al., 2005). Excess fat n
sis stored in adipose tissue and can be
mobilized to provide fuel to other organs 2
t(Large et al., 2004). Adipogenesis is an
area of intense interest due to the large c
oand growing prevalence of obesity in
western countries along with associated l
amedical problems including type 2 dia-
betes, hypertension, dyslipidemia, and b
iSyndrome X.
Elucidating the mechanism of adipo-
zgenesis is the subject of a considerable
body of literature. Adipogenesis occurs f
fvia a complex communication network
between various transcription factors t
iand the nuclear receptor PPARγ. PPARγ
is the terminal factor that controls adipo- (
fgenesis and the ultimate expression of
genes expressed in mature adipocytes, n
aincluding those encoding fatty-acid bind-
ing protein, lipoprotein receptor, lipopro- m
ptein lipase, glycerol kinase, and phospho-
enolpyruvate carboxykinase (Tontonoz w
det al., 1994; Morrison and Farmer, 2000;
Rosen and Spiegelman, 2001; Evans et H
sal., 2004). PPARγ is also the target of the
thiazolidinedione class of drugs used in c
mthe treatment of type 2 diabetes (Leh-
mann et al., 1995). Gain- and loss-of- m
bfunction studies have revealed that
PPARγ is required for differentiation of t
Kvarious cells, including the commonly
used 3T3-L1 cell line, mouse embryo fi- c
tbroblasts, and embryonic stem cells, to
adipocytes. Other transcription factors p
nsuch as C/EBPα, C/EBPβ, C/EBPδ,
PPARβ/δ, and ADD1/SREBP1c have also b
tbeen shown, under various circum-
stances, to influence the extent of adi- P
ppogenesis. Because they are among theCELL METABOLISM : FEBRUARY 2005 · VOL. 1irst transcription factors activated after g
tpplication of a hormonal stimulus of
AMP, insulin, and glucocorticoids to b
tT3-L1 cells, C/EBPβ and C/EBPδ are
andidate early initiators of adipogen- P
sis followed by expression of C/EBPα
nd PPARγ (Rosen et al., 2000). How- t
tver, it was firmly established using
PARγ-deficient cells that PPARγ, and δ
tot C/EBPα, is the terminal factor re-
ponsible for adipogenesis (Rosen et al., i
e002). These and other studies indicate
he existence of a transcription factor c
pascade, but there remains a wide gap
f knowledge between hormonal stimu- c
ration and activation of PPARγ (Rosen et
l., 2000, 2002). Two recent studies are p
teginning to connect more of the dots
n this transcription factor network. c
aNeonatal mice heterozygous for the
inc finger containing transcription b
Nactor KLF5, designated KLF+/−, were
ound to have reduced white adipose m
tissue, suggesting a role for this protein
n adipogenesis during development t
wOishi et al., 2005). While a reduction in
at, commonly found in genetically engi- C
teered mouse models, could be due to
number of other biochemical abnor- C
talities, several lines of evidence sup-
orted the contention that adipogenesis t
eas affected by lower KLF5 expression
ue to disruption of one KLF5 allele. a
iormonal stimulation of 3T3-L1 cells re-
ulted in induction of KLF5 that pre- k
(edes the accumulation of PPARγ2
RNA, and inhibition of KLF5 by a do- l
inant-negative form of the protein
locked hormone-induced differentia- l
tion. Embryonic fibroblasts derived from
LF5+/− also had an attenuated adipo- K
iyte differentiation response compared
o cells from wild-type mice, thus ex- t
ilaining the low adipose stores in neo-
ate KLF5+/− mice. This phenotype can i
ae accounted for in part by the finding
hat the KLF5 is able to activate the a
oPARγ2 promoter along with the C/EBP
roteins. Most interestingly, the KLF5 a· COPYRIGHT © 2005 ELSEVIER INC.ene is activated by C/EBPβ and δ and
hus joins the parade as another mem-
er of the transcription factor cascade
hat terminates with activation of the
PARγ2 gene and full adipogenesis.
From these and other studies, the ques-
ion arises, what induces expression of
he C/EBP genes, especially C/EBPβ and
? Krox20, another zinc finger-containing
ranscription factor, distinct from KLF5,
s enriched in adult adipose tissue. How-
ver, its role in adipogenesis was un-
lear because Krox20 was not ex-
ressed in fully differentiated 3T3-L1
ells in vitro. A series of experiments has
evealed that Krox20 is involved in adi-
ogenesis and may in fact be one of
he earliest genes activated after appli-
ation of the hormonal signals (Chen et
l., 2005). The Krox20 gene is rapidly
ut transiently induced in 3T3-L1 and
IH3T3 cells following hormone treat-
ent. Forced expression of Krox20 in
hese cells in the absence of hormone
reatment stimulated adipogenesis. This
as coincident with an induction of
/EBPβ expression that was likely due
o either a direct activation of the
/EBPβ promoter or indirect action
hrough a yet to be identified Krox20
arget. Expression of C/EBPδ was not
xamined. The finding that Krox20 is
mong the earliest genes activated dur-
ng adipogenesis is in keeping with its
nown role as an early growth response
Erg) gene that is activated by extracellu-
ar signals (Chen et al., 2005).
These two reports have expanded the
ist of members in the adipogenesis
ranscription factor cascade (Figure 1).
rox20 appears to be the earliest factor
nduced after hormone stimulation. It
hen activates C/EBPβ either directly or
ndirectly, possibly by activating another
ntermediary transcription factor, such
s a homeobox family protein. C/EBPβ
nd δ then directly activate expression
f the KLF5 gene, and finally C/EBPβ
nd δ and KLF5 together induce expres-85
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Figure 1. Model for the adipogenesis transcription factor cascade L
WAmong the earliest events following hormonal stimulation is the induction of Krox20, which in turn, either
(directly or indirectly through a homeobox factor, activates the expression of C/EBPβ and possibly δ. C/EBPβ
and δ then activate the expression of KLF5 that, in concert with C/EBPβ and δ, activates the PPARγ2 gene
M
and triggers conversion of preadipocytes to adipocytes. PPARγ then activates the expression of C/EBPα that
1feeds back and regulates the PPARγ gene. The black arrows indicate possible direct transcriptional activation
while the gray arrows denote possible pathways where there is no evidence for direct transcriptional acti- O
vation. s
Y
Msion of PPARγ2. PPARγ2 then activates p
the expression of C/EBPα, which feeds o
back and contributes to enhance ex- a
pression of the PPARγ gene. Thus, o
multiple factors control the PPARγ gene s
and drive adipogenesis. While Krox20 a
and KLF5 have filled in some of the gaps C
in the adipogenesis cascade, a number h
of questions remain unanswered. First, s
what activates the expression of Krox20 r
after application of the insulin and glu- e
cocorticoid hormone cocktail? Second, (
is there yet another transcription factor, m
possibly a homeobox protein target of t
Krox20, that controls C/EBPβ and possi- s
fbly δ? Third, is Krox20 critical for adi-86R
ogenesis in vivo? Fourth, are there B
ther target genes for KLF5 and Krox20,
Rnd do they play a role in maintenance
S
f the adult adipocyte phenotype or in 1
pecific physiological functions of the
Rdipocyte? As a final note, similar to the
F
/EBP proteins, both KLF5 and Krox20 B
ave important functions in other tis-
Tues. For example, KLF5 is a positive
a
egulator of SMemb that is associat- 1
dwith activated smooth muscle cells
WWatanabe et al., 1999). Among the
K
ysteries of biology is how networks of t
ranscription factors, expressed in a tis- e
ue-, time-, and hormone-dependent
ashion, control cell differentiation and Drganogenesis. The study of adipogen-
sis has revealed a complexity of mul-
iple steps required for getting fat.
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